市場調査レポート
商品コード
1298666
獣医分子診断市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Veterinary Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
獣医分子診断市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
|
獣医分子診断の世界市場規模は、2022年に6億3,490万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に8.8%の成長率(CAGR)を示し、2028年までに10億6,480万米ドルに達すると予測しています。
獣医分子診断は、従来のポリメラーゼ連鎖反応(PCR)や定量ポリメラーゼ連鎖反応(PCR)のような分子ベースの方法を用いて、臨床医が動物の間でウイルス、細菌、媒介病原体を幅広く検出、同定、遺伝子型判定するのを支援します。これらは少量の多様な生物学的試料を必要とし、核酸の迅速かつ高感度な検出と感染症の診断を可能にします。現在、動物保健センターや研究所では、動物疾病の迅速かつ特異的な診断を促進するために、複雑さの異なる分子技術の数々が使用されています。
畜産活動の増加は、食の安全に対する関心の高まりとともに、家畜のより良い診断と治療のための獣医分子診断の需要を喚起する主な要因の一つです。さらに、世界中でコロナウイルス病(COVID-19)が発生し、動物における感染の影響を分析するためのPCR検査の必要性が高まっています。これとは別に、核家族化の動向と所得水準の上昇に伴うペット飼育の増加が、ペットの人間化の高まりと相まって、市場の成長を後押ししています。これはまた、ペットを飼う親たちの間でペットの健康に対する関心が高まっているため、ペット保険への加入が増加していることにも起因しています。さらに、多くの国の行政機関が獣医学的診療や商業的動物生産プログラムを支援しており、その結果、世界中で獣医分子診断の導入が強化されています。これに加えて、全ゲノムシークエンシング(WGS)のような高度なジェノタイピング技術のイントロダクションが、カスタマイズされた試薬やキットの需要の急増と相まって、市場にプラスの影響を与えると予想されます。
The global veterinary molecular diagnostics market size reached US$ 634.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,064.8 Million by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028.
Veterinary molecular diagnostics assist clinicians in detecting, identifying, and genotyping a broad range of viral, bacterial, and vector-borne pathogens among animals using molecular-based methods, such as conventional and quantitative polymerase chain reaction (PCR). They require small amounts of a diverse spectrum of biological sample types, which further allow rapid and highly sensitive detection of nucleic acids and diagnosis of infectious diseases. At present, an array of molecular techniques of different complexity are used in veterinary health centers and research laboratories to facilitate the fast and specific diagnosis of animal diseases.
The escalating number of animal husbandry activities, along with the rising concerns about food safety, represents one of the major factors catalyzing the demand for veterinary molecular diagnostics for better diagnosis and treatment of livestock. Additionally, the outbreak of coronavirus disease (COVID-19) across the globe is driving the need for PCR testing to analyze the effect of the infection in animals. Apart from this, the increasing pet ownership on account of the emerging nuclear family trends and inflating income levels, coupled with the rising pet humanization, is bolstering the market growth. This can also be attributed to the increasing uptake of pet insurance policies due to the growing concerns among pet parents about the well-being of their pets. Moreover, governing agencies of numerous countries are supporting veterinary practices and commercial animal-production programs, which, in turn, is strengthening the adoption of veterinary molecular diagnostics around the world. Besides this, the introduction of advanced genotyping techniques, such as whole-genome sequencing (WGS), in confluence with the surging demand for customized reagents and kits, is anticipated to influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, animal type, disease type and end user.
Kits and Reagents
Instruments
Software and Services
Real Time PCR
Microarray
DNA Sequencing
Companion Animal
Livestock Animal
Vector-borne Diseases
Respiratory Pathogens
Diarrhea Pathogens
Others
Veterinary Hospitals
Clinical Laboratories
Research Institutes
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc. and Zoetis Inc.
Key Questions Answered in This Report
1. What was the size of the global veterinary molecular diagnostics market in 2022?
2. What is the expected growth rate of the global veterinary molecular diagnostics market during 2023-2028?
3. What are the key factors driving the global veterinary molecular diagnostics market?
4. What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
5. What is the breakup of the global veterinary molecular diagnostics market based on the product?
6. What is the breakup of the global veterinary molecular diagnostics market based on the technology?
7. What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
8. What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
9. What are the key regions in the global veterinary molecular diagnostics market?
10. Who are the key players/companies in the global veterinary molecular diagnostics market?